--- title: How AI-Powered Health Engagement Tools Build Trust Across Communities description: Acclinate’s AI-powered health engagement tools drive inclusive, community-based outreach, increasing representation in clinical research. image: https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/How-AI-Powered-Health-Engagement-Tools-Build-Trust-Across-Communities.jpg --- [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [eDICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros) - [Partners](https://www.acclinate.com/solutions/community-partners) - Company - [About Us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [News](https://news.acclinate.com) - Resources - [Resource Library](https://www.acclinate.com/resources) - [Blog](https://blog.acclinate.com) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [Glossary](https://www.acclinate.com/glossary) - [FAQ](https://www.acclinate.com/faq) - [Talk to Our Team](https://info.acclinate.com/get-in-touch) [![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302) [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [**NOWINCLUDED**Acclinate’s B2C community platform ](https://www.acclinate.com/products/nowincluded-the-community) - [**e-DICT**Acclinate’s patented AI-powered technology ](https://www.acclinate.com/products/e-dict) - Solutions - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials. ](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines. ](https://www.acclinate.com/solutions/for-cros) - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve. ](https://www.acclinate.com/solutions/community-partners) - Company - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation. ](https://www.acclinate.com/about) - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation. ](https://www.acclinate.com/careers) - Resources - [**Resources Hub** ](https://www.acclinate.com/resources) - [**Glossary** ](https://www.acclinate.com/glossary) - [**Press Kit** ](https://www.acclinate.com/press-kit) - [**Events** ](https://www.acclinate.com/events) - [**Blog** ](https://blog.acclinate.com/) - [**News** ](https://news.acclinate.com/) - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png) **FAQs** ](https://www.acclinate.com/faq) - [ Contact Us ](https://www.acclinate.com/contact-us) Stay up to date Get news directly in your inbox Topic All - [Affective Trust ](https://blog.acclinate.com/tag/affective-trust) - [Announcement ](https://blog.acclinate.com/tag/announcement) - [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software) - [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies) - [Community ](https://blog.acclinate.com/tag/community) - [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials) - [e-DICT™ ](https://blog.acclinate.com/tag/e-dict) - [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan) - [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials) - [Health Equity ](https://blog.acclinate.com/tag/health-equity) - [Partnerships ](https://blog.acclinate.com/tag/partnerships) - [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare) [Clinical Research Software](https://blog.acclinate.com/topic/clinical-research-software) # How AI-Powered Health Engagement Tools Build Trust Across Communities Acclinate’s AI-powered health engagement tools drive inclusive, community-based outreach, increasing representation in clinical research. ![How AI-Powered Health Engagement Tools Build Trust Across Communities](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/How-AI-Powered-Health-Engagement-Tools-Build-Trust-Across-Communities.jpg) Clinical Trial Diversity: What Does It Really Mean? Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t... Read More ![ Acclinate](https://blog.acclinate.com/hubfs/69b96486c4b036c19f462c19_acclinate-logo.png) [Acclinate](https://blog.acclinate.com/author/acclinate) Acclinate turns trust and data into better representation. Share this Post: [**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/how-ai-powered-health-engagement-tools-build-trust-across-communities) [**](https://twitter.com/home?status=https://blog.acclinate.com/how-ai-powered-health-engagement-tools-build-trust-across-communities) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/how-ai-powered-health-engagement-tools-build-trust-across-communities&title=How%20AI-Powered%20Health%20Engagement%20Tools%20Build%20Trust%20Across%20Communities) Stay up to date Get news directly in your inbox **Key Takeaways and Learnings**  - AI alone can’t build trust with underrepresented communities. It requires cultural insight, lived experience, and ongoing community partnership. - Predictive analytics + dynamic feedback = smarter outreach. Acclinate’s tools combine data-driven insights with continuous adaptation, helping teams connect meaningfully with difficult-to-reach communities. - AI, guided by cultural intelligence, supports targeted, personalized health outreach, which leads to more representative clinical research. - Omnichannel engagement drives results. AI tools such as e-DICT™ and NOWINCLUDED power integrated strategies that help sponsors meet diversity, cost, and timeline goals at once. - Discover the three steps organizations can take [to build relationships with communities of color](https://info.acclinate.com/3-steps-to-engage-communities-of-color).    Artificial intelligence (AI) is rapidly reshaping the way CROs and research sponsors connect with communities. But no matter how sophisticated the technology or precise the algorithms, AI cannot replace human insight.   Trust is essential, and that requires cultural fluency and real human connection.  Acclinate builds this trust through deep listening and relevant, community-centered AI design. Its AI-powered health engagement tools bridge gaps in clinical research participation by using data to inform, adapt, and engage.   Acclinate connects community building with data analysis to help pharmaceutical companies and CROs actively improve inclusion efforts. By aligning technology with cultural relevance, these tools cultivate trust and move outreach from transactional to transformative.  The result? Measurable improvements in participant diversity and stronger, more sustainable partnerships with underrepresented populations. [![Download Now – Mobilizing for Health Equity: 3 Steps to Engage Communities of Color](https://no-cache.hubspot.com/cta/default/19943632/interactive-192647109192.png) ](https://blog.acclinate.com/hs/cta/wi/redirect?encryptedPayload=AVxigLIPdX9%2BCv2B8fNYvQKSHjCkPh5qrgBWJL3Xni22%2B80oQh4ocGsvJRFztEJ2uJeH1hgFJtKTFtjwZHvKNuiLVYtnrnFEBfwOkwlJDadRvM1v88L4bXhwpGCCiwDg2HZ5%2FJsPfyxfuHuwRY9fpVRsB%2Fa2004zwJlqhc9i7lmXgUD2lyNAI%2BGveHhdbiYW7Uz1ad%2F84QprNoMCknF8UVt2%2FoCXC9XX&webInteractiveContentId=192647109192&portalId=19943632) ## The Challenge of Trust in Health Engagement Communities of color often remain justifiably wary of healthcare systems, especially clinical research. Their distrust is based on historical injustices, ongoing discrimination, and structural barriers to care.  [Conventional outreach strategies often fall short](https://blog.acclinate.com/challenges-of-the-traditional-clinical-recruitment-process) because they ignore the cultural, logistical, and historical factors that influence participation in clinical research. Studies show that meaningful recruitment and retention, especially among underserved populations, [require community-engaged approaches](https://nap.nationalacademies.org/catalog/26479/improving-representation-in-clinical-trials-and-research-building-research-equity). Acclinate maintains that trust is built through authentic human connection—high-touch supports high-tech, not the other way around.   When guided by cultural insight, Acclinate’s AI tools enable more precise, equitable outreach at scale by:  - Using participation probability scores to predict likelihood of engagement - Pinpointing individuals and communities most open to participation - Combining algorithmic targeting with ongoing human feedback to adapt outreach strategies  Acclinate’s AI-powered health engagement tools strengthen trust, bolstering [equity-driven, culturally aware engagement strategies](https://www.drugdiscoverytrends.com/community-based-clinical-trials-diversity/) that honor the lived experience of potential research participants. ## **Offering the Right ****Digital Tools for Community Health**  Acclinate’s approach to inclusive engagement is to meet communities where they are—both online and in person. Two AI-powered health engagement tools support this mission: e-DICT™, a predictive analytics engine for smarter recruitment, and NOWINCLUDED, a health education and community platform. They work in tandem with Acclinate’s HealthSense platform, which identifies localized trends. Together, they support targeted outreach, real-time engagement tracking, and ongoing relationship-building across diverse populations.  AI alone is inadequate, however. Too often, biased datasets reflect the gaps of the past rather than the needs of the present. [Many AI models reinforce healthcare inequities](https://fas.org/publication/improving-health-equity-through-ai/) because they were trained on incomplete, non-diverse datasets. Transparency and accountability are also lacking in many systems, making it difficult for clinicians and communities to trust AI-driven recommendations. And when they overemphasize socioeconomic factors, these algorithms can [unintentionally harm the very populations they aim to serve](https://www.nature.com/articles/s41746-023-00913-9).   That’s why Acclinate’s approach combines people-first design with robust analytics to ensure equity and trust.  Unlike AI tools trained on non-representative data, Acclinate’s platforms integrate community insight with predictive analytics.  Rather than replacing human judgment, Acclinate’s AI enhances knowledge gained from direct community engagement. A diverse team shapes every aspect of the model’s development to ensure alignment with the real-world perspectives of the communities it serves. These people-first digital tools for community health aren’t limited to clinical research; they can scale across broader health equity initiatives like preventive care, chronic disease outreach, and patient education.  ###  **e-DICT™: Predictive, real-time engagement intelligence**  [e-DICT™ is Acclinate’s proprietary analytics platform](https://blog.acclinate.com/e-DICT-transforms-clinical-trial-recruitment) designed to advance health equity through smarter, data-informed outreach. It assigns participation probability scores using the PPI algorithm and behavioral data, allowing organizations to identify individuals more likely to engage in research or health programs. This streamlines recruitment and outreach by focusing efforts where they’re most likely to connect.  e-DICT™ also provides real-time reporting across digital and in-person outreach. It captures where, how, and to what extent communities are interacting with campaigns—allowing partners to refine messaging and outreach strategies quickly.  e-DICT™ expedites recruitment, allowing CROs and sponsors to meet time, cost, and equity goals while accelerating patient enrollment.  ### **NOWINCLUDED: A community hub for health connection**  NOWINCLUDED is a digital platform created for communities of color facing specific health conditions. Integrated with e-DICT™, it offers culturally relevant health education, peer connection, and opportunities to participate in research or care initiatives.   This approach is already helping healthcare organizations see measurable improvements in participation and representation as they build long-term community trust.  ## **Integrated Outreach That Adapts in Real Time**  Acclinate’s strength lies in the seamless integration of its digital tools for community health. By combining e-DICT™’s predictive analytics with the grassroots reach of NOWINCLUDED, Acclinate supports a blended outreach strategy that includes digital platforms, community events, influencers, and local health initiatives. This omnichannel approach gives sponsors and CROs a comprehensive view of engagement patterns as they develop in real time. They can see what’s working and what needs to be adjusted.  Tailored omnichannel engagement improves recruitment outcomes and fosters the trust needed for long-term representation in research. But what makes Acclinate’s AI-powered health engagement tools so effective is their ability to adapt: As new data flows in from both digital and in-person interactions, e-DICT™ continuously updates participation trends and behavioral signals, creating a feedback loop that sustains—not just initiates—inclusion.  Dynamic PPI scores help organizations refine messaging, channels, and timing to align with community sentiment. This continuous adaptation keeps outreach relevant, responsive, and grounded in lived experience. Outreach becomes an evolving conversation. ## **Personalized Health Outreach****, Culturally Relevant Engagement**  Acclinate delivers personalized health outreach by combining its HealthSense platform, which identifies localized health trends, with the engagement intelligence of e-DICT™. e-DICT™ translates HealthSense’s insights into predictive engagement scores, and NOWINCLUDED activates communities through relevant education and connection.  This integration allows organizations to tailor outreach to the specific health needs, preferences, and cultural contexts of underrepresented populations, ensuring that messages are delivered through the channels communities trust most.  By using real-time data and AI-driven insights such as the PPI, Acclinate humanizes outreach, moving beyond generic campaigns to create meaningful, trust-based connections. This blend of innovative analytics and grassroots engagement means CROs and sponsors can design equity-focused initiatives that overcome barriers to participation.   Although clinical research inclusion is a core focus, these digital tools for community health also support broader efforts—from chronic disease management to health education—driving sustained empowerment and improved outcomes for communities of color.  ## **Tracking Engagement and Building Accountability**  Acclinate’s e-DICT™ platform brings transparency to community outreach, giving organizations behavioral data and digital engagement analytics. This visibility allows sponsors and CROs to track what’s working, make data-driven adjustments, and stay accountable to their inclusivity goals.  By continuously monitoring participation trends and engagement patterns, e-DICT™ helps shorten recruitment timelines and ensure outreach remains culturally relevant.  For CROs and sponsors, [ongoing access to community insights](https://blog.acclinate.com/the-launch-lens-weaving-community-engagement-throughout-drug-development-commercialization) leads to:   - Accelerated recruitment with more representative participant pools, - Higher-quality data that drives better care for diverse populations, and - Sustainable impact through insights that inform strategy.  ## **Inclusive Research, Powered by AI**  Pharmaceutical companies and CROs face increasing pressure to conduct clinical research that is not only faster and more efficient but also truly representative. Acclinate’s AI-powered health engagement tools help them by streamlining the identification and engagement of underrepresented populations, shortening recruitment timelines, and delivering actionable insights. This empowers sponsors and CROs to close representation gaps and build genuine connections with communities of color.  Trust takes time and requires personalized health outreach. When AI is guided by cultural intelligence, outreach becomes scalable, sustainable, and inclusive. Ready for a front-row view of how Acclinate uses AI to build meaningful connections? [Schedule a 1:1 meeting with our team](https://www.acclinate.com/request-a-demo).  ## Recent Posts [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) June 25, 2026 3 Min Read Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr... Read More [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) June 25, 2026 3 Min Read For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle... Read More [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) June 25, 2026 3 Min Read Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s... Read More [![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) [ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) June 24, 2026 1 Min Read Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h... Read More [![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) March 2, 2026 3 Min Read For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality. Read More [![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) February 16, 2026 3 Min Read Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h... Read More [![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) February 9, 2026 3 Min Read Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical... Read More [![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) February 2, 2026 2 Min Read Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ... Read More [![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) January 26, 2026 3 Min Read Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited... Read More [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) June 25, 2026 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World Read More ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) June 25, 2026 Clinical Trial Generalizability: What Regulators Will Scrutinize Next Read More ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) June 25, 2026 Site Engagement Index (SEI): Measuring What Actually Builds Trust Read More ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) ![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp) ![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp) ![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp) ## Ready to Measure Your True Impact? Partner with Acclinate to turn mission into measurable, data-driven action. [ Get Started ](https://www.acclinate.com/contact-us) [![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [e-DICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [CROs](https://www.acclinate.com/solutions/for-cros) - [Community Partners](https://www.acclinate.com/solutions/community-partners) - Resources - [Resources Hub](https://www.acclinate.com/resources) - [Glossary](https://www.acclinate.com/glossary) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [News](https://news.acclinate.com/) - [Blog](https://blog.acclinate.com/) - [FAQs](https://www.acclinate.com/faq) - Company - [About us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [Contact Us](https://www.acclinate.com/contact-us) - Follow Us - [** Linkedin](https://www.linkedin.com/company/acclinateinc/) - [Privacy Policy](https://www.acclinate.com/privacy) - [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Acclinate", "url" : "https://blog.acclinate.com/author/acclinate" }, "dateModified" : "2025-12-01T17:00:11.839Z", "datePublished" : "2025-07-16T21:26:38.000Z", "headline" : "How AI-Powered Health Engagement Tools Build Trust Across Communities", "image" : [ "https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/How-AI-Powered-Health-Engagement-Tools-Build-Trust-Across-Communities.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.acclinate.com/how-ai-powered-health-engagement-tools-build-trust-across-communities", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png" }, "name" : "Acclinate" } } ```